» Articles » PMID: 24676865

Reduced HTERT Protein Levels Are Associated with DNA Aneuploidy in the Colonic Mucosa of Patients Suffering from Longstanding Ulcerative Colitis

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2014 Mar 29
PMID 24676865
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Longstanding ulcerative colitis (UC) is a disease of chronic inflammation of the colon. It is associated with the development of colorectal cancer through a multistep process including increasing degrees of dysplasia and DNA-ploidy changes. However, not all UC patients will develop these characteristics even during lifelong disease, and patients may therefore be divided into progressors who develop dysplasia or cancer, and non-progressors who do not exhibit such changes. In the present study, the amount of hTERT, the catalytic subunit of the enzyme telomerase, was estimated by using peroxidase immunohistochemistry (IHC) in a set of progressor and non-progressor UC colectomies. The protein levels in the colonic mucosa of the progressors and non‑progressors were compared, and further comparisons between different categories of dysplastic development and to DNA-ploidy status within the progressors were made. Levels of hTERT were elevated in the colonic mucosa of the progressors and non-progressors when compared to non-UC control samples, but no difference was observed between the hTERT levels in the mucosa of progressors and non-progressors. The levels of hTERT associated with levels of Ki67 to a significant degree within the non-progressors. hTERT expression in lesions with DNA-aneuploidy were decreased as compared to diploid lesions, when stratified for different classes of colonic morphology. Our results indicate an association between hTERT protein expression and aneuploidy in UC-progressor colons, and also a possible protective mechanism in the association between hTERT and Ki67, against development of malignant features within the mucosa of a UC-colon.

Citing Articles

Telomerase: a target for colorectal cancer treatment?.

Kouroumalis E Cell Cycle. 2015; 14(22):3513-4.

PMID: 26379105 PMC: 4825774. DOI: 10.1080/15384101.2015.1032638.


TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis.

Friis-Ottessen M, Burum-Auensen E, Schjolberg A, Ekstrom P, Andersen S, Clausen O Int J Mol Med. 2014; 35(1):24-30.

PMID: 25333414 PMC: 4249752. DOI: 10.3892/ijmm.2014.1974.

References
1.
Hammarberg C, Slezak P, Tribukait B . Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer. 1984; 53(2):291-5. DOI: 10.1002/1097-0142(19840115)53:2<291::aid-cncr2820530218>3.0.co;2-b. View

2.
Gerling M, Nousiainen K, Hautaniemi S, Kruger S, Fritzsche B, Homann N . Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis. Inflamm Bowel Dis. 2013; 19(4):691-703. PMC: 7587454. DOI: 10.1097/MIB.0b013e31827eeaa4. View

3.
Meling G, Clausen O, Bergan A, Schjolberg A, Rognum T . Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis. Br J Cancer. 1991; 64(2):339-44. PMC: 1977516. DOI: 10.1038/bjc.1991.302. View

4.
MACDOUGALL I . THE CANCER RISK IN ULCERATIVE COLITIS. Lancet. 1964; 2(7361):655-8. DOI: 10.1016/s0140-6736(64)92474-2. View

5.
Cobanoglu Simsek B, Pehlivan S, Karaoglu A . Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features. Ann Diagn Pathol. 2010; 14(6):413-7. DOI: 10.1016/j.anndiagpath.2010.06.007. View